This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-200c-3p | ABAT | 6.47 | 0 | 0.06 | 0.94069 | MirTarget | -0.18 | 0.00957 | NA | |
2 | hsa-miR-200c-3p | ACTC1 | 6.47 | 0 | -6.26 | 0 | MirTarget | -0.55 | 0 | NA | |
3 | hsa-miR-200c-3p | ADAMTS3 | 6.47 | 0 | -3.48 | 0.00158 | miRNATAP | -0.38 | 6.0E-5 | NA | |
4 | hsa-miR-200c-3p | ADCY2 | 6.47 | 0 | -5.74 | 0.00019 | MirTarget; miRNATAP | -0.37 | 0.00506 | NA | |
5 | hsa-miR-200c-3p | AFF3 | 6.47 | 0 | -4.69 | 0 | MirTarget; miRNATAP | -0.55 | 0 | NA | |
6 | hsa-miR-200c-3p | AMOTL2 | 6.47 | 0 | -0.94 | 0.10811 | MirTarget; miRNATAP | -0.13 | 0.00723 | NA | |
7 | hsa-miR-200c-3p | AP1S2 | 6.47 | 0 | -2.97 | 0 | MirTarget; miRNATAP | -0.33 | 0 | NA | |
8 | hsa-miR-200c-3p | ARHGAP20 | 6.47 | 0 | -3.56 | 0.00051 | MirTarget; miRNATAP | -0.52 | 0 | NA | |
9 | hsa-miR-200c-3p | ARHGAP28 | 6.47 | 0 | -2.52 | 0.04263 | MirTarget | -0.36 | 0.0008 | NA | |
10 | hsa-miR-200c-3p | ARHGAP6 | 6.47 | 0 | -5.45 | 0 | MirTarget | -0.51 | 0 | NA | |
11 | hsa-miR-200c-3p | ARHGEF17 | 6.47 | 0 | -2.19 | 1.0E-5 | miRNATAP | -0.18 | 2.0E-5 | NA | |
12 | hsa-miR-200c-3p | ARL10 | 6.47 | 0 | -0.75 | 0.35282 | mirMAP | -0.23 | 0.00086 | NA | |
13 | hsa-miR-200c-3p | ARL15 | 6.47 | 0 | -0.85 | 0.14947 | MirTarget | -0.15 | 0.00286 | NA | |
14 | hsa-miR-200c-3p | ARL2BP | 6.47 | 0 | -0.97 | 0.00154 | miRNATAP | -0.12 | 0 | NA | |
15 | hsa-miR-200c-3p | ASAP1 | 6.47 | 0 | -0.15 | 0.71428 | MirTarget; miRNATAP | -0.11 | 0.00254 | NA | |
16 | hsa-miR-200c-3p | ATP11C | 6.47 | 0 | -0.87 | 0.09047 | MirTarget | -0.11 | 0.01482 | NA | |
17 | hsa-miR-200c-3p | ATXN1 | 6.47 | 0 | -1.43 | 0.00387 | MirTarget; miRNATAP | -0.18 | 2.0E-5 | NA | |
18 | hsa-miR-200c-3p | BACH2 | 6.47 | 0 | -2.73 | 0.00174 | mirMAP | -0.28 | 0.00014 | NA | |
19 | hsa-miR-200c-3p | BASP1 | 6.47 | 0 | -1.12 | 0.32909 | miRNATAP | -0.29 | 0.00304 | NA | |
20 | hsa-miR-200c-3p | BCL2 | 6.47 | 0 | -3.06 | 1.0E-5 | miRNAWalker2 validate; miRTarBase; mirMAP | -0.2 | 0.00073 | NA | |
21 | hsa-miR-200c-3p | BNC2 | 6.47 | 0 | -6.04 | 0 | MirTarget | -0.65 | 0 | NA | |
22 | hsa-miR-200c-3p | C11orf87 | 6.47 | 0 | -3.96 | 0.00131 | miRNATAP | -0.41 | 0.00012 | NA | |
23 | hsa-miR-200c-3p | C17orf51 | 6.47 | 0 | -1.61 | 0.06048 | mirMAP | -0.25 | 0.00075 | NA | |
24 | hsa-miR-200c-3p | CACNA1C | 6.47 | 0 | -5.48 | 0 | MirTarget | -0.48 | 0 | NA | |
25 | hsa-miR-200c-3p | CALU | 6.47 | 0 | -0.85 | 0.0346 | MirTarget | -0.11 | 0.00144 | NA | |
26 | hsa-miR-200c-3p | CBL | 6.47 | 0 | -0.22 | 0.60145 | MirTarget; mirMAP | -0.1 | 0.00481 | NA | |
27 | hsa-miR-200c-3p | CDK17 | 6.47 | 0 | -1.12 | 0.0009 | MirTarget; miRNATAP | -0.11 | 0.00023 | NA | |
28 | hsa-miR-200c-3p | CDK6 | 6.47 | 0 | 0.5 | 0.55124 | mirMAP | -0.18 | 0.01104 | NA | |
29 | hsa-miR-200c-3p | CELF2 | 6.47 | 0 | -2.48 | 0.00126 | mirMAP; miRNATAP | -0.27 | 4.0E-5 | NA | |
30 | hsa-miR-200c-3p | CEP68 | 6.47 | 0 | -1.77 | 1.0E-5 | MirTarget | -0.13 | 0.00021 | NA | |
31 | hsa-miR-200c-3p | CFL2 | 6.47 | 0 | -3.33 | 0 | MirTarget; miRNATAP | -0.21 | 0 | 23497265 | We characterized one of the target genes of miR-200c CFL2 and demonstrated that CFL2 is overexpressed in aggressive breast cancer cell lines and can be significantly down-regulated by exogenous miR-200c |
32 | hsa-miR-200c-3p | CHD9 | 6.47 | 0 | -0.3 | 0.4758 | mirMAP; miRNATAP | -0.11 | 0.00301 | NA | |
33 | hsa-miR-200c-3p | CHN2 | 6.47 | 0 | -2.38 | 0.00853 | MirTarget | -0.18 | 0.01746 | NA | |
34 | hsa-miR-200c-3p | CHRDL1 | 6.47 | 0 | -10 | 0 | MirTarget | -0.93 | 0 | NA | |
35 | hsa-miR-200c-3p | CHST11 | 6.47 | 0 | 0.01 | 0.99092 | mirMAP | -0.2 | 0.00421 | NA | |
36 | hsa-miR-200c-3p | CHST2 | 6.47 | 0 | -0.56 | 0.58452 | miRNATAP | -0.2 | 0.02082 | NA | |
37 | hsa-miR-200c-3p | CITED2 | 6.47 | 0 | -2.82 | 0 | miRNATAP | -0.15 | 0.00238 | NA | |
38 | hsa-miR-200c-3p | CLIC4 | 6.47 | 0 | -2.07 | 1.0E-5 | MirTarget; miRNATAP | -0.2 | 0 | NA | |
39 | hsa-miR-200c-3p | CLIP2 | 6.47 | 0 | -1.79 | 0.00423 | MirTarget; miRNATAP | -0.18 | 0.00063 | NA | |
40 | hsa-miR-200c-3p | CNN3 | 6.47 | 0 | -1.93 | 6.0E-5 | MirTarget; miRNATAP | -0.16 | 6.0E-5 | NA | |
41 | hsa-miR-200c-3p | CNTFR | 6.47 | 0 | -4.16 | 0.0243 | miRNATAP | -0.62 | 9.0E-5 | NA | |
42 | hsa-miR-200c-3p | CNTN1 | 6.47 | 0 | -2.85 | 0.12833 | MirTarget; miRNATAP | -0.32 | 0.04972 | NA | |
43 | hsa-miR-200c-3p | CNTN4 | 6.47 | 0 | -4.52 | 0.00012 | miRNATAP | -0.47 | 0 | NA | |
44 | hsa-miR-200c-3p | CREB5 | 6.47 | 0 | -1.55 | 0.13969 | miRNATAP | -0.23 | 0.01024 | NA | |
45 | hsa-miR-200c-3p | CTNND2 | 6.47 | 0 | -1.3 | 0.30842 | MirTarget; miRNATAP | -0.25 | 0.02473 | NA | |
46 | hsa-miR-200c-3p | CYP1B1 | 6.47 | 0 | -3.73 | 0.00104 | miRNATAP | -0.5 | 0 | 25860934 | Loss of miR 200c up regulates CYP1B1 and confers docetaxel resistance in renal cell carcinoma; Additionally miR-200c which is significantly down-regulated in RCC regulates CYP1B1 expression and activity; An inverse association was also observed between the expression levels of miR-200c and CYP1B1 protein in RCC tissues; Restoration of docetaxel resistance by exogenous expression of CYP1B1 in miR-200c-over-expressing cells indicates that CYP1B1 is a functional target of miR-200c; These results suggest that CYP1B1 up-regulation mediated by low miR-200c is one of the mechanisms underlying resistance of RCC cells to docetaxel; Therefore expression of CYP1B1 and miR-200c in RCC may be useful as a prediction for docetaxel response |
47 | hsa-miR-200c-3p | CYTH3 | 6.47 | 0 | -1.45 | 0.00123 | MirTarget | -0.14 | 0.00023 | NA | |
48 | hsa-miR-200c-3p | DACT1 | 6.47 | 0 | -3.37 | 0.00113 | miRNATAP | -0.47 | 0 | NA | |
49 | hsa-miR-200c-3p | DDIT4L | 6.47 | 0 | -4.36 | 0.00321 | MirTarget | -0.29 | 0.02198 | NA | |
50 | hsa-miR-200c-3p | DIXDC1 | 6.47 | 0 | -4.24 | 0 | MirTarget | -0.35 | 0 | NA | |
51 | hsa-miR-200c-3p | DLC1 | 6.47 | 0 | -3.66 | 0 | miRNATAP | -0.39 | 0 | NA | |
52 | hsa-miR-200c-3p | DMD | 6.47 | 0 | -4.18 | 0.00037 | miRNATAP | -0.28 | 0.0054 | NA | |
53 | hsa-miR-200c-3p | DNAJB5 | 6.47 | 0 | -2.37 | 0.00017 | miRNATAP | -0.26 | 0 | NA | |
54 | hsa-miR-200c-3p | DOCK4 | 6.47 | 0 | -2.11 | 0.00043 | MirTarget | -0.33 | 0 | NA | |
55 | hsa-miR-200c-3p | DRP2 | 6.47 | 0 | -1.91 | 0.00658 | mirMAP | -0.26 | 1.0E-5 | NA | |
56 | hsa-miR-200c-3p | DTNA | 6.47 | 0 | -4.44 | 4.0E-5 | MirTarget | -0.38 | 5.0E-5 | NA | |
57 | hsa-miR-200c-3p | DUSP1 | 6.47 | 0 | -2.32 | 0.01163 | MirTarget; miRNATAP | -0.19 | 0.0147 | NA | |
58 | hsa-miR-200c-3p | DZIP1 | 6.47 | 0 | -2.74 | 0.00323 | MirTarget | -0.31 | 9.0E-5 | NA | |
59 | hsa-miR-200c-3p | EDNRA | 6.47 | 0 | -3.86 | 1.0E-5 | miRNAWalker2 validate; miRNATAP | -0.48 | 0 | NA | |
60 | hsa-miR-200c-3p | ENTPD1 | 6.47 | 0 | -1.65 | 0 | MirTarget; mirMAP | -0.17 | 0 | NA | |
61 | hsa-miR-200c-3p | ETS1 | 6.47 | 0 | -1.33 | 0.02728 | MirTarget; miRNATAP | -0.21 | 4.0E-5 | NA | |
62 | hsa-miR-200c-3p | ETV5 | 6.47 | 0 | -1.13 | 0.19728 | MirTarget; miRNATAP | -0.15 | 0.03993 | 27276064 | Another study suggested that ERM expression was regulated directly by miR-200c and had a critical role in miR-200c suppressing cell migration |
63 | hsa-miR-200c-3p | F2RL2 | 6.47 | 0 | -2.19 | 0.0286 | MirTarget | -0.34 | 6.0E-5 | NA | |
64 | hsa-miR-200c-3p | FAM19A2 | 6.47 | 0 | -1.96 | 0.02444 | MirTarget | -0.19 | 0.01302 | NA | |
65 | hsa-miR-200c-3p | FAT3 | 6.47 | 0 | -3.48 | 0.01525 | MirTarget; miRNATAP | -0.49 | 6.0E-5 | NA | |
66 | hsa-miR-200c-3p | FBLN5 | 6.47 | 0 | -4.86 | 0 | miRNAWalker2 validate; miRTarBase | -0.42 | 0 | NA | |
67 | hsa-miR-200c-3p | FGF18 | 6.47 | 0 | -3.02 | 0.02212 | miRNATAP | -0.26 | 0.02167 | NA | |
68 | hsa-miR-200c-3p | FGF2 | 6.47 | 0 | -4.74 | 0 | mirMAP | -0.51 | 0 | NA | |
69 | hsa-miR-200c-3p | FHL1 | 6.47 | 0 | -6.47 | 0 | MirTarget | -0.7 | 0 | NA | |
70 | hsa-miR-200c-3p | FKBP14 | 6.47 | 0 | -0.6 | 0.25887 | mirMAP | -0.16 | 0.00058 | NA | |
71 | hsa-miR-200c-3p | FLI1 | 6.47 | 0 | -2.51 | 0.00017 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
72 | hsa-miR-200c-3p | FLNA | 6.47 | 0 | -2.75 | 2.0E-5 | miRNAWalker2 validate | -0.29 | 0 | NA | |
73 | hsa-miR-200c-3p | FLT1 | 6.47 | 0 | -2.51 | 2.0E-5 | miRNAWalker2 validate; miRTarBase; MirTarget | -0.22 | 1.0E-5 | NA | |
74 | hsa-miR-200c-3p | FN1 | 6.47 | 0 | -1.36 | 0.25051 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.53 | 0 | NA | |
75 | hsa-miR-200c-3p | FOXF1 | 6.47 | 0 | -3.07 | 9.0E-5 | MirTarget | -0.21 | 0.00153 | NA | |
76 | hsa-miR-200c-3p | FOXK1 | 6.47 | 0 | -0.47 | 0.32974 | miRNATAP | -0.11 | 0.00931 | NA | |
77 | hsa-miR-200c-3p | FOXP1 | 6.47 | 0 | -1.09 | 0.01887 | mirMAP | -0.11 | 0.00439 | NA | |
78 | hsa-miR-200c-3p | FRMD6 | 6.47 | 0 | -1.61 | 0.08207 | miRNATAP | -0.32 | 5.0E-5 | NA | |
79 | hsa-miR-200c-3p | FSTL1 | 6.47 | 0 | -2.21 | 0.00396 | MirTarget | -0.24 | 0.00032 | NA | |
80 | hsa-miR-200c-3p | FYN | 6.47 | 0 | -2.7 | 5.0E-5 | miRNATAP | -0.26 | 0 | NA | |
81 | hsa-miR-200c-3p | FZD4 | 6.47 | 0 | -2.84 | 4.0E-5 | mirMAP | -0.23 | 8.0E-5 | NA | |
82 | hsa-miR-200c-3p | GABRB3 | 6.47 | 0 | -3.82 | 0.02528 | mirMAP | -0.64 | 1.0E-5 | NA | |
83 | hsa-miR-200c-3p | GEM | 6.47 | 0 | -3.68 | 0 | MirTarget; miRNATAP | -0.33 | 0 | NA | |
84 | hsa-miR-200c-3p | GFRA1 | 6.47 | 0 | -6.72 | 0 | mirMAP | -0.92 | 0 | NA | |
85 | hsa-miR-200c-3p | GJC1 | 6.47 | 0 | -2.92 | 0.00079 | MirTarget; miRNATAP | -0.17 | 0.01977 | NA | |
86 | hsa-miR-200c-3p | GLI3 | 6.47 | 0 | -1.93 | 0.0645 | miRNATAP | -0.44 | 0 | NA | |
87 | hsa-miR-200c-3p | GLIS2 | 6.47 | 0 | -1.46 | 0.04526 | miRNATAP | -0.16 | 0.01016 | NA | |
88 | hsa-miR-200c-3p | GPM6A | 6.47 | 0 | -8.84 | 0 | miRNATAP | -0.68 | 0 | NA | |
89 | hsa-miR-200c-3p | GPR146 | 6.47 | 0 | -3.24 | 0 | miRNATAP | -0.11 | 0.01728 | NA | |
90 | hsa-miR-200c-3p | GPRASP2 | 6.47 | 0 | -3.07 | 0 | MirTarget | -0.21 | 2.0E-5 | NA | |
91 | hsa-miR-200c-3p | GREM1 | 6.47 | 0 | -1.9 | 0.09368 | MirTarget | -0.41 | 2.0E-5 | NA | |
92 | hsa-miR-200c-3p | HCFC2 | 6.47 | 0 | -0.95 | 0.00435 | miRNATAP | -0.12 | 2.0E-5 | NA | |
93 | hsa-miR-200c-3p | HHIP | 6.47 | 0 | -3.26 | 0.02749 | mirMAP | -0.27 | 0.03043 | NA | |
94 | hsa-miR-200c-3p | HIVEP3 | 6.47 | 0 | 1.08 | 0.18783 | miRNATAP | -0.24 | 0.00047 | NA | |
95 | hsa-miR-200c-3p | HLF | 6.47 | 0 | -4.18 | 0.00043 | MirTarget; miRNATAP | -0.34 | 0.00085 | NA | |
96 | hsa-miR-200c-3p | IL6ST | 6.47 | 0 | -0.27 | 0.81784 | mirMAP | -0.22 | 0.02973 | NA | |
97 | hsa-miR-200c-3p | IRS1 | 6.47 | 0 | -2.43 | 0.00336 | miRNATAP | -0.33 | 0 | NA | |
98 | hsa-miR-200c-3p | ITGA1 | 6.47 | 0 | -1.26 | 0.08839 | MirTarget | -0.2 | 0.00124 | NA | |
99 | hsa-miR-200c-3p | ITPR1 | 6.47 | 0 | -3.7 | 0 | miRNATAP | -0.36 | 0 | NA | |
100 | hsa-miR-200c-3p | ITPR2 | 6.47 | 0 | -0.34 | 0.55073 | MirTarget | -0.13 | 0.00652 | NA | |
101 | hsa-miR-200c-3p | JAG1 | 6.47 | 0 | 0.3 | 0.66716 | miRNAWalker2 validate | -0.23 | 0.00015 | NA | |
102 | hsa-miR-200c-3p | JAZF1 | 6.47 | 0 | -3.33 | 0 | MirTarget; miRNATAP | -0.29 | 0 | NA | |
103 | hsa-miR-200c-3p | JUN | 6.47 | 0 | -1.4 | 0.02101 | MirTarget | -0.12 | 0.02177 | NA | |
104 | hsa-miR-200c-3p | KANK1 | 6.47 | 0 | -1.88 | 0.00218 | MirTarget | -0.21 | 6.0E-5 | NA | |
105 | hsa-miR-200c-3p | KCND2 | 6.47 | 0 | -2.76 | 0.00595 | MirTarget; miRNATAP | -0.37 | 1.0E-5 | NA | |
106 | hsa-miR-200c-3p | KCTD15 | 6.47 | 0 | -0.19 | 0.80405 | MirTarget; miRNATAP | -0.17 | 0.00988 | NA | |
107 | hsa-miR-200c-3p | KDR | 6.47 | 0 | -3.79 | 0 | miRNATAP | -0.38 | 0 | 24205206 | MiR 200c increases the radiosensitivity of non small cell lung cancer cell line A549 by targeting VEGF VEGFR2 pathway; MiR-200c at the nexus of epithelial-mesenchymal transition EMT is predicted to target VEGFR2; The purpose of this study is to test the hypothesis that regulation of VEGFR2 pathway by miR-200c could modulate the radiosensitivity of cancer cells; Bioinformatic analysis luciferase reporter assays and biochemical assays were carried out to validate VEGFR2 as a direct target of miR-200c; We identified VEGFR2 as a novel target of miR-200c |
108 | hsa-miR-200c-3p | KIAA0040 | 6.47 | 0 | -0.68 | 0.2064 | MirTarget | -0.11 | 0.01255 | NA | |
109 | hsa-miR-200c-3p | KIAA1462 | 6.47 | 0 | -4.22 | 0 | MirTarget | -0.36 | 0 | NA | |
110 | hsa-miR-200c-3p | KIF13A | 6.47 | 0 | -0.77 | 0.21453 | miRNATAP | -0.1 | 0.04987 | NA | |
111 | hsa-miR-200c-3p | KLF9 | 6.47 | 0 | -3.7 | 0 | miRNAWalker2 validate; miRTarBase; miRNATAP | -0.24 | 2.0E-5 | NA | |
112 | hsa-miR-200c-3p | KLHDC1 | 6.47 | 0 | -2.41 | 0.00025 | MirTarget | -0.18 | 0.00125 | NA | |
113 | hsa-miR-200c-3p | KLHL3 | 6.47 | 0 | -2.04 | 0.00444 | miRNATAP | -0.18 | 0.00349 | NA | |
114 | hsa-miR-200c-3p | LAMC1 | 6.47 | 0 | -1.13 | 0.04875 | MirTarget; miRNATAP | -0.11 | 0.03256 | NA | |
115 | hsa-miR-200c-3p | LATS2 | 6.47 | 0 | -1.64 | 0.00068 | miRNATAP | -0.14 | 0.00059 | NA | |
116 | hsa-miR-200c-3p | LCA5 | 6.47 | 0 | -1.85 | 0.0069 | MirTarget | -0.12 | 0.03516 | NA | |
117 | hsa-miR-200c-3p | LHFP | 6.47 | 0 | -3.72 | 0 | MirTarget; miRNATAP | -0.36 | 0 | NA | |
118 | hsa-miR-200c-3p | LIX1L | 6.47 | 0 | -2.88 | 0 | MirTarget | -0.25 | 0 | NA | |
119 | hsa-miR-200c-3p | MAF | 6.47 | 0 | -1.68 | 0.06488 | miRNATAP | -0.28 | 0.00032 | NA | |
120 | hsa-miR-200c-3p | MARCH1 | 6.47 | 0 | 1.32 | 0.04357 | MirTarget | -0.15 | 0.0083 | NA | |
121 | hsa-miR-200c-3p | MARCH8 | 6.47 | 0 | -0.9 | 0.18552 | MirTarget | -0.16 | 0.00606 | NA | |
122 | hsa-miR-200c-3p | MBNL2 | 6.47 | 0 | -1.12 | 0.04591 | miRNATAP | -0.12 | 0.01377 | NA | |
123 | hsa-miR-200c-3p | MEF2D | 6.47 | 0 | -1.6 | 0 | mirMAP | -0.12 | 1.0E-5 | NA | |
124 | hsa-miR-200c-3p | MEGF10 | 6.47 | 0 | -3.63 | 0.00058 | MirTarget | -0.37 | 4.0E-5 | NA | |
125 | hsa-miR-200c-3p | MEX3B | 6.47 | 0 | -1.91 | 0.02006 | miRNATAP | -0.23 | 0.00103 | NA | |
126 | hsa-miR-200c-3p | MFAP5 | 6.47 | 0 | -6.02 | 0.00032 | miRNATAP | -0.54 | 0.00015 | NA | |
127 | hsa-miR-200c-3p | MITF | 6.47 | 0 | -4.45 | 0 | miRNATAP | -0.3 | 0 | NA | |
128 | hsa-miR-200c-3p | MPDZ | 6.47 | 0 | -3.48 | 0.00068 | MirTarget | -0.23 | 0.00827 | NA | |
129 | hsa-miR-200c-3p | MPRIP | 6.47 | 0 | -1.56 | 6.0E-5 | MirTarget; miRNATAP | -0.11 | 0.00143 | NA | |
130 | hsa-miR-200c-3p | MRVI1 | 6.47 | 0 | -4.88 | 0 | MirTarget | -0.52 | 0 | NA | |
131 | hsa-miR-200c-3p | MSN | 6.47 | 0 | -0.63 | 0.39017 | miRNAWalker2 validate; miRTarBase; MirTarget | -0.32 | 0 | NA | |
132 | hsa-miR-200c-3p | MSRB3 | 6.47 | 0 | -5.12 | 0 | mirMAP | -0.51 | 0 | NA | |
133 | hsa-miR-200c-3p | MTSS1L | 6.47 | 0 | -0.88 | 0.10869 | miRNATAP | -0.1 | 0.03058 | NA | |
134 | hsa-miR-200c-3p | MYO5A | 6.47 | 0 | -0.13 | 0.84407 | mirMAP | -0.21 | 0.00021 | NA | |
135 | hsa-miR-200c-3p | NALCN | 6.47 | 0 | -2.97 | 0.0246 | MirTarget | -0.4 | 0.00038 | NA | |
136 | hsa-miR-200c-3p | NAP1L5 | 6.47 | 0 | -2.41 | 0.00107 | MirTarget; miRNATAP | -0.14 | 0.02804 | NA | |
137 | hsa-miR-200c-3p | NCAM1 | 6.47 | 0 | -7.27 | 0 | miRTarBase | -0.54 | 0 | NA | |
138 | hsa-miR-200c-3p | NCS1 | 6.47 | 0 | -1.45 | 0.01609 | miRNATAP | -0.25 | 0 | NA | |
139 | hsa-miR-200c-3p | NDN | 6.47 | 0 | -5.07 | 0 | MirTarget; miRNATAP | -0.46 | 0 | NA | |
140 | hsa-miR-200c-3p | NDST1 | 6.47 | 0 | -0.18 | 0.708 | miRNATAP | -0.13 | 0.00125 | NA | |
141 | hsa-miR-200c-3p | NEGR1 | 6.47 | 0 | -5.45 | 0 | miRNATAP | -0.51 | 0 | NA | |
142 | hsa-miR-200c-3p | NEK9 | 6.47 | 0 | -1.02 | 0.00036 | MirTarget | -0.11 | 1.0E-5 | NA | |
143 | hsa-miR-200c-3p | NFASC | 6.47 | 0 | -2.43 | 0.02593 | miRNATAP | -0.46 | 0 | 23185507 | miR 200c targets a NF κB up regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer |
144 | hsa-miR-200c-3p | NFIA | 6.47 | 0 | -0.82 | 0.18121 | MirTarget; miRNATAP | -0.12 | 0.01827 | NA | |
145 | hsa-miR-200c-3p | NLGN4X | 6.47 | 0 | -3.16 | 0.05081 | miRNATAP | -0.48 | 0.00053 | NA | |
146 | hsa-miR-200c-3p | NOVA1 | 6.47 | 0 | -6.3 | 0 | MirTarget; miRNATAP | -0.69 | 0 | NA | |
147 | hsa-miR-200c-3p | NR2F2 | 6.47 | 0 | -3.23 | 2.0E-5 | miRNATAP | -0.18 | 0.00551 | NA | |
148 | hsa-miR-200c-3p | NR5A2 | 6.47 | 0 | -3.5 | 0 | miRNATAP | -0.29 | 1.0E-5 | NA | |
149 | hsa-miR-200c-3p | NRIP1 | 6.47 | 0 | 0.2 | 0.71343 | MirTarget; miRNATAP | -0.11 | 0.01997 | NA | |
150 | hsa-miR-200c-3p | NRIP3 | 6.47 | 0 | 0.14 | 0.8767 | mirMAP | -0.17 | 0.01974 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 66 | 1672 | 1.127e-15 | 5.242e-12 |
2 | CELL DEVELOPMENT | 57 | 1426 | 9.444e-14 | 2.197e-10 |
3 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 39 | 771 | 1.25e-12 | 1.938e-09 |
4 | TISSUE DEVELOPMENT | 56 | 1518 | 4.217e-12 | 4.905e-09 |
5 | REGULATION OF CELL DIFFERENTIATION | 55 | 1492 | 7.051e-12 | 6.561e-09 |
6 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 38 | 788 | 1.046e-11 | 6.955e-09 |
7 | CIRCULATORY SYSTEM DEVELOPMENT | 38 | 788 | 1.046e-11 | 6.955e-09 |
8 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 45 | 1142 | 9.495e-11 | 5.523e-08 |
9 | REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS | 42 | 1021 | 1.181e-10 | 6.104e-08 |
10 | VASCULATURE DEVELOPMENT | 27 | 469 | 2.826e-10 | 1.315e-07 |
11 | REGULATION OF NEURON DIFFERENTIATION | 29 | 554 | 5.515e-10 | 2.333e-07 |
12 | NEUROGENESIS | 49 | 1402 | 7.585e-10 | 2.941e-07 |
13 | BLOOD VESSEL MORPHOGENESIS | 23 | 364 | 1.066e-09 | 3.814e-07 |
14 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 48 | 1395 | 1.946e-09 | 6.467e-07 |
15 | REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 33 | 750 | 2.752e-09 | 8.538e-07 |
16 | REGULATION OF CELL DEVELOPMENT | 35 | 836 | 3.166e-09 | 9.206e-07 |
17 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 44 | 1275 | 9.426e-09 | 2.58e-06 |
18 | EPITHELIUM DEVELOPMENT | 36 | 945 | 2.139e-08 | 4.976e-06 |
19 | CELLULAR COMPONENT MORPHOGENESIS | 35 | 900 | 2.056e-08 | 4.976e-06 |
20 | BIOLOGICAL ADHESION | 38 | 1032 | 2.049e-08 | 4.976e-06 |
21 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 51 | 1656 | 2.274e-08 | 5.039e-06 |
22 | HEART DEVELOPMENT | 24 | 466 | 2.503e-08 | 5.293e-06 |
23 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 33 | 823 | 2.63e-08 | 5.32e-06 |
24 | RESPONSE TO WOUNDING | 25 | 563 | 2.201e-07 | 4.096e-05 |
25 | INTRACELLULAR SIGNAL TRANSDUCTION | 47 | 1572 | 2.156e-07 | 4.096e-05 |
26 | CELL JUNCTION ORGANIZATION | 14 | 185 | 2.432e-07 | 4.353e-05 |
27 | POSITIVE REGULATION OF CELL COMMUNICATION | 46 | 1532 | 2.631e-07 | 4.534e-05 |
28 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 34 | 957 | 2.841e-07 | 4.722e-05 |
29 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 32 | 872 | 3.227e-07 | 5.178e-05 |
30 | MESENCHYME DEVELOPMENT | 14 | 190 | 3.372e-07 | 5.184e-05 |
31 | REGULATION OF CELL PROLIFERATION | 45 | 1496 | 3.453e-07 | 5.184e-05 |
32 | LOCOMOTION | 37 | 1114 | 4.245e-07 | 6.172e-05 |
33 | ORGAN MORPHOGENESIS | 31 | 841 | 4.553e-07 | 6.42e-05 |
34 | REGULATION OF CELL ADHESION | 26 | 629 | 4.93e-07 | 6.747e-05 |
35 | REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS | 15 | 229 | 5.827e-07 | 7.746e-05 |
36 | REGULATION OF CELL SUBSTRATE ADHESION | 13 | 173 | 7.129e-07 | 9.215e-05 |
37 | EPITHELIAL CELL DIFFERENTIATION | 22 | 495 | 1.192e-06 | 0.0001499 |
38 | POSITIVE REGULATION OF LOCOMOTION | 20 | 420 | 1.296e-06 | 0.0001587 |
39 | CELL JUNCTION ASSEMBLY | 11 | 129 | 1.496e-06 | 0.0001785 |
40 | EMBRYO DEVELOPMENT | 31 | 894 | 1.655e-06 | 0.0001925 |
41 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 16 | 285 | 1.892e-06 | 0.0002147 |
42 | POSITIVE REGULATION OF CELL DEVELOPMENT | 21 | 472 | 2.066e-06 | 0.0002289 |
43 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 22 | 513 | 2.14e-06 | 0.0002316 |
44 | REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 11 | 138 | 2.907e-06 | 0.0003074 |
45 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 19 | 408 | 3.324e-06 | 0.0003437 |
46 | CELL MOTILITY | 29 | 835 | 3.559e-06 | 0.0003523 |
47 | LOCALIZATION OF CELL | 29 | 835 | 3.559e-06 | 0.0003523 |
48 | ACTIN FILAMENT BASED PROCESS | 20 | 450 | 3.697e-06 | 0.0003584 |
49 | HEAD DEVELOPMENT | 26 | 709 | 4.478e-06 | 0.0004252 |
50 | SYNAPSE ORGANIZATION | 11 | 145 | 4.702e-06 | 0.0004376 |
51 | SINGLE ORGANISM CELL ADHESION | 20 | 459 | 4.969e-06 | 0.0004534 |
52 | POSITIVE REGULATION OF RESPONSE TO STIMULUS | 50 | 1929 | 5.521e-06 | 0.0004847 |
53 | REGULATION OF GTPASE ACTIVITY | 25 | 673 | 5.519e-06 | 0.0004847 |
54 | RESPONSE TO ENDOGENOUS STIMULUS | 41 | 1450 | 5.767e-06 | 0.000497 |
55 | TUBE DEVELOPMENT | 22 | 552 | 6.914e-06 | 0.000585 |
56 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 42 | 1518 | 7.455e-06 | 0.0006195 |
57 | POSITIVE REGULATION OF GENE EXPRESSION | 46 | 1733 | 7.629e-06 | 0.0006228 |
58 | REGULATION OF CELL PROJECTION ORGANIZATION | 22 | 558 | 8.194e-06 | 0.0006414 |
59 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 47 | 1791 | 8.066e-06 | 0.0006414 |
60 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 25 | 689 | 8.271e-06 | 0.0006414 |
61 | POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT | 19 | 437 | 8.879e-06 | 0.0006692 |
62 | POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 29 | 876 | 8.917e-06 | 0.0006692 |
63 | TUBE MORPHOGENESIS | 16 | 323 | 9.326e-06 | 0.0006888 |
64 | MORPHOGENESIS OF AN EPITHELIUM | 18 | 400 | 9.657e-06 | 0.0007021 |
65 | POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION | 9 | 103 | 1.114e-05 | 0.0007977 |
66 | ANGIOGENESIS | 15 | 293 | 1.206e-05 | 0.0008499 |
67 | TISSUE MORPHOGENESIS | 21 | 533 | 1.336e-05 | 0.0009278 |
68 | VASCULOGENESIS | 7 | 59 | 1.451e-05 | 0.0009927 |
69 | NEGATIVE REGULATION OF LOCOMOTION | 14 | 263 | 1.526e-05 | 0.001025 |
70 | CELL PROJECTION ORGANIZATION | 29 | 902 | 1.542e-05 | 0.001025 |
71 | EMBRYONIC MORPHOGENESIS | 21 | 539 | 1.579e-05 | 0.001035 |
72 | REGULATION OF EPITHELIAL CELL MIGRATION | 11 | 166 | 1.705e-05 | 0.0011 |
73 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 38 | 1360 | 1.726e-05 | 0.0011 |
74 | CELL SUBSTRATE JUNCTION ASSEMBLY | 6 | 41 | 1.768e-05 | 0.001112 |
75 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 47 | 1848 | 1.819e-05 | 0.001128 |
76 | NEURON PROJECTION DEVELOPMENT | 21 | 545 | 1.861e-05 | 0.001139 |
77 | REGULATION OF MEMBRANE POTENTIAL | 16 | 343 | 1.96e-05 | 0.001184 |
78 | POSITIVE REGULATION OF NEURON DIFFERENTIATION | 15 | 306 | 2.008e-05 | 0.00119 |
79 | REGULATION OF ION HOMEOSTASIS | 12 | 201 | 2.021e-05 | 0.00119 |
80 | REGULATION OF BODY FLUID LEVELS | 20 | 506 | 2.057e-05 | 0.001197 |
81 | NEGATIVE REGULATION OF CELL DEATH | 28 | 872 | 2.23e-05 | 0.001275 |
82 | REGULATION OF CELL MORPHOGENESIS | 21 | 552 | 2.246e-05 | 0.001275 |
83 | NEURON DEVELOPMENT | 24 | 687 | 2.339e-05 | 0.001296 |
84 | NEURON DIFFERENTIATION | 28 | 874 | 2.324e-05 | 0.001296 |
85 | WOUND HEALING | 19 | 470 | 2.444e-05 | 0.001322 |
86 | HEMOSTASIS | 15 | 311 | 2.425e-05 | 0.001322 |
87 | REGULATION OF ENDOTHELIAL CELL MIGRATION | 9 | 114 | 2.529e-05 | 0.001352 |
88 | NEPHRON DEVELOPMENT | 9 | 115 | 2.712e-05 | 0.001434 |
89 | REGULATION OF CELL MATRIX ADHESION | 8 | 90 | 3.043e-05 | 0.001591 |
90 | NEGATIVE REGULATION OF CELL COMMUNICATION | 34 | 1192 | 3.314e-05 | 0.001713 |
91 | POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION | 7 | 67 | 3.373e-05 | 0.001724 |
92 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 45 | 1784 | 3.454e-05 | 0.001747 |
93 | SYSTEM PROCESS | 45 | 1785 | 3.501e-05 | 0.001752 |
94 | REGULATION OF CHEMOTAXIS | 11 | 180 | 3.613e-05 | 0.001788 |
95 | ACTIN FILAMENT BASED MOVEMENT | 8 | 93 | 3.86e-05 | 0.001871 |
96 | NEPHRON EPITHELIUM DEVELOPMENT | 8 | 93 | 3.86e-05 | 0.001871 |
97 | ACTION POTENTIAL | 8 | 94 | 4.17e-05 | 0.002 |
98 | POSITIVE REGULATION OF HYDROLASE ACTIVITY | 28 | 905 | 4.303e-05 | 0.002031 |
99 | REGULATION OF CELL DEATH | 39 | 1472 | 4.321e-05 | 0.002031 |
100 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 30 | 1008 | 4.631e-05 | 0.002155 |
101 | POSITIVE REGULATION OF CELL PROLIFERATION | 26 | 814 | 4.844e-05 | 0.002232 |
102 | REGULATION OF HYDROLASE ACTIVITY | 36 | 1327 | 5.428e-05 | 0.002428 |
103 | RESPONSE TO ORGANIC CYCLIC COMPOUND | 28 | 917 | 5.411e-05 | 0.002428 |
104 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 19 | 498 | 5.342e-05 | 0.002428 |
105 | CELL PART MORPHOGENESIS | 22 | 633 | 5.573e-05 | 0.00247 |
106 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 8 | 98 | 5.627e-05 | 0.00247 |
107 | REGULATION OF SYSTEM PROCESS | 19 | 507 | 6.776e-05 | 0.002947 |
108 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 30 | 1036 | 7.6e-05 | 0.003129 |
109 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 30 | 1036 | 7.6e-05 | 0.003129 |
110 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 9 | 131 | 7.554e-05 | 0.003129 |
111 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 41 | 1618 | 7.321e-05 | 0.003129 |
112 | RENAL SYSTEM PROCESS | 8 | 102 | 7.485e-05 | 0.003129 |
113 | EXTRACELLULAR STRUCTURE ORGANIZATION | 14 | 304 | 7.44e-05 | 0.003129 |
114 | POSITIVE REGULATION OF VASCULATURE DEVELOPMENT | 9 | 133 | 8.494e-05 | 0.003426 |
115 | BEHAVIOR | 19 | 516 | 8.542e-05 | 0.003426 |
116 | REGULATION OF VASCULATURE DEVELOPMENT | 12 | 233 | 8.509e-05 | 0.003426 |
117 | CELL CELL ADHESION | 21 | 608 | 8.995e-05 | 0.00356 |
118 | RENAL TUBULE DEVELOPMENT | 7 | 78 | 9.028e-05 | 0.00356 |
119 | MUSCLE STRUCTURE DEVELOPMENT | 17 | 432 | 9.113e-05 | 0.003563 |
120 | REGULATION OF TRANSPORT | 44 | 1804 | 9.363e-05 | 0.00363 |
121 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 10 | 167 | 9.671e-05 | 0.003719 |
122 | REGULATION OF MAPK CASCADE | 22 | 660 | 0.0001023 | 0.003902 |
123 | MUSCLE ORGAN DEVELOPMENT | 13 | 277 | 0.0001111 | 0.004204 |
124 | REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION | 13 | 278 | 0.0001152 | 0.004322 |
125 | NEURON PROJECTION MORPHOGENESIS | 16 | 402 | 0.0001286 | 0.004788 |
126 | MELANOCYTE DIFFERENTIATION | 4 | 20 | 0.0001346 | 0.004972 |
127 | PLATELET ACTIVATION | 9 | 142 | 0.0001403 | 0.005139 |
128 | TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 23 | 724 | 0.0001448 | 0.005224 |
129 | TISSUE MIGRATION | 7 | 84 | 0.0001445 | 0.005224 |
130 | CIRCULATORY SYSTEM PROCESS | 15 | 366 | 0.0001517 | 0.00543 |
131 | REGULATION OF KINASE ACTIVITY | 24 | 776 | 0.0001554 | 0.005486 |
132 | HEART PROCESS | 7 | 85 | 0.0001556 | 0.005486 |
133 | PIGMENTATION | 7 | 86 | 0.0001675 | 0.00586 |
134 | MEMBRANE DEPOLARIZATION | 6 | 61 | 0.0001741 | 0.006002 |
135 | MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL | 5 | 39 | 0.0001739 | 0.006002 |
136 | CARTILAGE DEVELOPMENT | 9 | 147 | 0.0001823 | 0.006236 |
137 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 43 | 1805 | 0.0001913 | 0.00645 |
138 | POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING | 6 | 62 | 0.0001906 | 0.00645 |
139 | NEGATIVE REGULATION OF CELL PROLIFERATION | 21 | 643 | 0.0001945 | 0.006511 |
140 | DEVELOPMENTAL PIGMENTATION | 5 | 40 | 0.0001965 | 0.006531 |
141 | NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 23 | 740 | 0.0001988 | 0.00656 |
142 | PROTEIN PHOSPHORYLATION | 27 | 944 | 0.0002151 | 0.00705 |
143 | UROGENITAL SYSTEM DEVELOPMENT | 13 | 299 | 0.0002357 | 0.007669 |
144 | NEGATIVE REGULATION OF CELL ADHESION | 11 | 223 | 0.0002433 | 0.00786 |
145 | POSITIVE REGULATION OF MAPK CASCADE | 17 | 470 | 0.000248 | 0.007959 |
146 | MODULATION OF SYNAPTIC TRANSMISSION | 13 | 301 | 0.0002514 | 0.008013 |
147 | POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION | 13 | 303 | 0.000268 | 0.008484 |
148 | STEM CELL DIFFERENTIATION | 10 | 190 | 0.0002772 | 0.008713 |
149 | KIDNEY EPITHELIUM DEVELOPMENT | 8 | 125 | 0.0003074 | 0.009598 |
150 | REGULATION OF CELL JUNCTION ASSEMBLY | 6 | 68 | 0.0003172 | 0.009839 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING | 24 | 629 | 5.471e-06 | 0.001992 |
2 | NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY | 36 | 1199 | 6.238e-06 | 0.001992 |
3 | MOLECULAR FUNCTION REGULATOR | 39 | 1353 | 6.431e-06 | 0.001992 |
4 | SEQUENCE SPECIFIC DNA BINDING | 32 | 1037 | 1.245e-05 | 0.002892 |
5 | REGULATORY REGION NUCLEIC ACID BINDING | 26 | 818 | 5.253e-05 | 0.008133 |
6 | PROTEIN DOMAIN SPECIFIC BINDING | 22 | 624 | 4.511e-05 | 0.008133 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CELL JUNCTION | 47 | 1151 | 9.949e-12 | 5.81e-09 |
2 | CELL PROJECTION | 57 | 1786 | 7.366e-10 | 2.151e-07 |
3 | MEMBRANE REGION | 42 | 1134 | 2.799e-09 | 5.449e-07 |
4 | NEURON PROJECTION | 35 | 942 | 6.334e-08 | 9.247e-06 |
5 | NEURON PART | 41 | 1265 | 1.784e-07 | 2.084e-05 |
6 | SOMATODENDRITIC COMPARTMENT | 27 | 650 | 2.665e-07 | 2.594e-05 |
7 | MEMBRANE MICRODOMAIN | 16 | 288 | 2.167e-06 | 0.0001808 |
8 | POSTSYNAPSE | 18 | 378 | 4.448e-06 | 0.0002634 |
9 | SYNAPSE | 27 | 754 | 4.51e-06 | 0.0002634 |
10 | PLASMA MEMBRANE REGION | 31 | 929 | 3.643e-06 | 0.0002634 |
11 | EXCITATORY SYNAPSE | 12 | 197 | 1.654e-05 | 0.0006899 |
12 | CELL BODY | 20 | 494 | 1.458e-05 | 0.0006899 |
13 | PERIKARYON | 9 | 108 | 1.638e-05 | 0.0006899 |
14 | DENDRITE | 19 | 451 | 1.382e-05 | 0.0006899 |
15 | SYNAPSE PART | 22 | 610 | 3.215e-05 | 0.001252 |
16 | ACTIN FILAMENT | 7 | 70 | 4.491e-05 | 0.001639 |
17 | CELL CELL JUNCTION | 15 | 383 | 0.0002476 | 0.008034 |
18 | SYNAPTIC MEMBRANE | 12 | 261 | 0.0002455 | 0.008034 |
19 | SARCOLEMMA | 8 | 125 | 0.0003074 | 0.009447 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | hsa04510_Focal_adhesion | 16 | 200 | 1.514e-08 | 2.726e-06 | |
2 | hsa04270_Vascular_smooth_muscle_contraction | 10 | 116 | 4.083e-06 | 0.0003675 | |
3 | hsa04151_PI3K_AKT_signaling_pathway | 17 | 351 | 6.587e-06 | 0.0003952 | |
4 | hsa04014_Ras_signaling_pathway | 13 | 236 | 2.151e-05 | 0.0009679 | |
5 | hsa04720_Long.term_potentiation | 7 | 70 | 4.491e-05 | 0.001617 | |
6 | hsa04912_GnRH_signaling_pathway | 8 | 101 | 6.979e-05 | 0.002094 | |
7 | hsa04970_Salivary_secretion | 7 | 89 | 0.0002075 | 0.005005 | |
8 | hsa04540_Gap_junction | 7 | 90 | 0.0002225 | 0.005005 | |
9 | hsa04010_MAPK_signaling_pathway | 12 | 268 | 0.0003124 | 0.00616 | |
10 | hsa04722_Neurotrophin_signaling_pathway | 8 | 127 | 0.0003422 | 0.00616 | |
11 | hsa04971_Gastric_acid_secretion | 6 | 74 | 0.0005017 | 0.00821 | |
12 | hsa04512_ECM.receptor_interaction | 6 | 85 | 0.001047 | 0.0157 | |
13 | hsa04012_ErbB_signaling_pathway | 6 | 87 | 0.001182 | 0.01636 | |
14 | hsa04666_Fc_gamma_R.mediated_phagocytosis | 6 | 95 | 0.001859 | 0.02391 | |
15 | hsa04960_Aldosterone.regulated_sodium_reabsorption | 4 | 42 | 0.002462 | 0.02753 | |
16 | hsa04916_Melanogenesis | 6 | 101 | 0.002535 | 0.02753 | |
17 | hsa04730_Long.term_depression | 5 | 70 | 0.0026 | 0.02753 | |
18 | hsa04020_Calcium_signaling_pathway | 8 | 177 | 0.002917 | 0.02917 | |
19 | hsa04070_Phosphatidylinositol_signaling_system | 5 | 78 | 0.004156 | 0.03937 | |
20 | hsa04514_Cell_adhesion_molecules_.CAMs. | 6 | 136 | 0.01065 | 0.09584 | |
21 | hsa04910_Insulin_signaling_pathway | 6 | 138 | 0.01139 | 0.09761 | |
22 | hsa04972_Pancreatic_secretion | 5 | 101 | 0.01215 | 0.0994 | |
23 | hsa00533_Glycosaminoglycan_biosynthesis_._keratan_sulfate | 2 | 15 | 0.0171 | 0.1338 | |
24 | hsa04390_Hippo_signaling_pathway | 6 | 154 | 0.01865 | 0.1368 | |
25 | hsa04114_Oocyte_meiosis | 5 | 114 | 0.01957 | 0.1368 | |
26 | hsa04370_VEGF_signaling_pathway | 4 | 76 | 0.01976 | 0.1368 | |
27 | hsa04664_Fc_epsilon_RI_signaling_pathway | 4 | 79 | 0.02243 | 0.1496 | |
28 | hsa04810_Regulation_of_actin_cytoskeleton | 7 | 214 | 0.02701 | 0.1736 | |
29 | hsa04380_Osteoclast_differentiation | 5 | 128 | 0.03035 | 0.1836 | |
30 | hsa04914_Progesterone.mediated_oocyte_maturation | 4 | 87 | 0.03059 | 0.1836 | |
31 | hsa04210_Apoptosis | 4 | 89 | 0.03287 | 0.1909 | |
32 | hsa04650_Natural_killer_cell_mediated_cytotoxicity | 5 | 136 | 0.03791 | 0.2133 | |
33 | hsa04340_Hedgehog_signaling_pathway | 3 | 56 | 0.04031 | 0.2198 | |
34 | hsa04310_Wnt_signaling_pathway | 5 | 151 | 0.05495 | 0.2909 | |
35 | hsa04144_Endocytosis | 6 | 203 | 0.05865 | 0.2925 | |
36 | hsa04660_T_cell_receptor_signaling_pathway | 4 | 108 | 0.05936 | 0.2925 | |
37 | hsa04630_Jak.STAT_signaling_pathway | 5 | 155 | 0.06013 | 0.2925 | |
38 | hsa04115_p53_signaling_pathway | 3 | 69 | 0.06716 | 0.3181 | |
39 | hsa00230_Purine_metabolism | 5 | 162 | 0.06985 | 0.3224 | |
40 | hsa04670_Leukocyte_transendothelial_migration | 4 | 117 | 0.07492 | 0.3368 | |
41 | hsa04520_Adherens_junction | 3 | 73 | 0.07672 | 0.3368 | |
42 | hsa04662_B_cell_receptor_signaling_pathway | 3 | 75 | 0.0817 | 0.3502 | |
43 | hsa04360_Axon_guidance | 4 | 130 | 0.1006 | 0.4213 | |
44 | hsa04530_Tight_junction | 4 | 133 | 0.1071 | 0.4381 | |
45 | hsa04062_Chemokine_signaling_pathway | 5 | 189 | 0.1148 | 0.458 | |
46 | hsa04962_Vasopressin.regulated_water_reabsorption | 2 | 44 | 0.1196 | 0.458 | |
47 | hsa04973_Carbohydrate_digestion_and_absorption | 2 | 44 | 0.1196 | 0.458 | |
48 | hsa04150_mTOR_signaling_pathway | 2 | 52 | 0.1566 | 0.5871 | |
49 | hsa04976_Bile_secretion | 2 | 71 | 0.2501 | 0.8647 | |
50 | hsa04260_Cardiac_muscle_contraction | 2 | 77 | 0.2803 | 0.9174 | |
51 | hsa04620_Toll.like_receptor_signaling_pathway | 2 | 102 | 0.4032 | 1 | |
52 | hsa04141_Protein_processing_in_endoplasmic_reticulum | 2 | 168 | 0.667 | 1 | |
53 | hsa04740_Olfactory_transduction | 2 | 388 | 0.9693 | 1 |